In humans, VL ROCK1 activity positively correlates with glucose disposal in lean subjects, while insulin-stimulated ROCK1 activity is impaired in those with diabetes or obesity, possibly due to elevated levels of the ROCK1 antagonist RhoE (35). This evidence concerns the gene ROCK1 and Obesity.